Coronavirus-killing tech available to AU businesses
Sustainable solutions provider iugis is making UV-C disinfection technology available to commercial markets in Australia and New Zealand following increased demands to protect health and safety in public spaces and workplaces.
Establishing a partnership with US-based Surfacide, iugis is putting its ultraviolet light energy technology and training in the hands of Australian and New Zealand businesses to help them give customers confidence in the cleanliness of hard surfaces as coronavirus restrictions are lifted.
Primarily used in hospitals, the technology emits UV-C energy to kill coronaviruses, influenza, staph, fungus, mould and bacteria plus a multitude of other drug-resistant organisms. Multiple emitters are placed in an area and, through a process of laser mapping, all high-touch surfaces within the area are disinfected. Depending on the size of the area, this can be completed in as little as five minutes.
According to iugis CEO Bill Papas, employers will go to great lengths to ensure the safety of their customers and staff — more so than ever before.
“The COVID-19 pandemic has shown us the need for regular disinfection of high-touch surfaces, with recent peer-reviewed research indicating coronaviruses can persist on surfaces and remain infectious for an average of four to five days, and in some cases up to nine days.
“Surfacide’s ability to disinfect surfaces with confidence, providing a detailed record of the process, with real-time analytics available via a cloud-based portal, is far superior to manual bio cleaning methods and doesn’t require the use of chemicals,” he said.
“We have seen the businesses of many of our customers severely impacted by this pandemic and they want to be able to promote to their customers they are providing a safe environment when they reopen.
“Hotels, offices, clubs and sporting facilities would all benefit from Surfacide, as well as businesses that have continued to operate during these difficult times, such as aged-care facilities, supermarkets, food manufacturers and processors, and shopping centres.”
Originating from the USA, the Helios disinfection system is used in operating theatres and wards where the highest standard of disinfection is required to reduce healthcare-associated infections. It is reported to reduce acquired infections by 99.9999% and conforms with Australian therapeutic goods regulations.
Non-invasive 'virtual' biopsy for skin cancer diagnosis
Researchers have developed a new imaging method that allows clinicians to analyse the skin...
UTI vaccines could prevent infection for nine years
MV140 is a new vaccine for recurrent UTIs and is administered with two sprays of a...
What's the key to retaining rural GPs?
Understanding doctors' decisions to stay or leave, once recruited, could provide insights on...
